EBOLA RAPID ASSAY DEVELOPMENT CONSORTIUM
Organized by: James Lyons-Weiler
Current tests for Ebola take days, and a device that can detect a virus directly does not exist. A device capable of giving a visible response to the presence of Ebola in saliva will be an essential part of the national and global response to the 2014 outbreak by reducing the rate of spread of the virus throughout the human population. Field screening in airports currently only involve questions on points of origin and taking travelers' temperates. Funds will be used to directly support six projects to develop and test a device that will passively sample saliva, detect viral proteins, amplify the signal of detection, and produce a visible change in a membrane enclosed within the device. The device will be used to triage patients, for surveillance on the health care setting, and provide rapid detection of Ebola and other viral agents in the military theatre.